Literature DB >> 17479178

Chemokines at large: in-vivo mechanisms of their transport, presentation and clearance.

Ian G Colditz1, Martin A Schneider, Monika Pruenster, Antal Rot.   

Abstract

Compelling evidence implicates chemokines in the induction of leukocyte emigration from blood into tissues. This arguably most fundamental effect of chemokines is accomplished by triggering cognate classical G-protein-coupled chemokine receptors on the leukocyte surface. In vitro, these same receptors mediate leukocyte migration; however, the mechanisms of chemokine-induced migration differ between in-vivo and in-vitro settings. Leukocyte egress from blood is greatly influenced by haemodynamic conditions and requires full cooperation of endothelial cells. The behaviour of chemokines in their "native habitat" in vivo is controlled by their interaction with several accessory molecules which influence immobilisation, transport, clearance and degradation of chemokines and thereby determine the sites and duration of their action. Here we discuss peculiarities of the in vivo actions of chemokines, the mechanisms of chemokine interaction with receptors and auxiliary molecules including interceptors, glycosaminoglycans and enzymes and illustrate how these interactions influence the outcome of chemokine activities in vivo.

Entities:  

Mesh:

Substances:

Year:  2007        PMID: 17479178

Source DB:  PubMed          Journal:  Thromb Haemost        ISSN: 0340-6245            Impact factor:   5.249


  25 in total

1.  The monomer-dimer equilibrium and glycosaminoglycan interactions of chemokine CXCL8 regulate tissue-specific neutrophil recruitment.

Authors:  Pavani Gangavarapu; Lavanya Rajagopalan; Deepthi Kolli; Antonieta Guerrero-Plata; Roberto P Garofalo; Krishna Rajarathnam
Journal:  J Leukoc Biol       Date:  2011-12-02       Impact factor: 4.962

Review 2.  The role of chemokines in the recruitment of lymphocytes to the liver.

Authors:  Ye H Oo; Shishir Shetty; David H Adams
Journal:  Dig Dis       Date:  2010-05-07       Impact factor: 2.404

Review 3.  How do chemokines navigate neutrophils to the target site: Dissecting the structural mechanisms and signaling pathways.

Authors:  Krishna Rajarathnam; Michael Schnoor; Ricardo M Richardson; Sudarshan Rajagopal
Journal:  Cell Signal       Date:  2018-11-19       Impact factor: 4.315

Review 4.  Therapeutic targeting of chemokine interactions in atherosclerosis.

Authors:  Rory R Koenen; Christian Weber
Journal:  Nat Rev Drug Discov       Date:  2010-02       Impact factor: 84.694

5.  A model of GAG/MIP-2/CXCR2 interfaces and its functional effects.

Authors:  Deepa Rajasekaran; Camille Keeler; Mansoor A Syed; Matthew C Jones; Jeffrey K Harrison; Dianqing Wu; Vineet Bhandari; Michael E Hodsdon; Elias J Lolis
Journal:  Biochemistry       Date:  2012-07-02       Impact factor: 3.162

6.  Posttranslational modification of the NH2-terminal region of CXCL5 by proteases or peptidylarginine Deiminases (PAD) differently affects its biological activity.

Authors:  Anneleen Mortier; Tamara Loos; Mieke Gouwy; Isabelle Ronsse; Jo Van Damme; Paul Proost
Journal:  J Biol Chem       Date:  2010-07-14       Impact factor: 5.157

Review 7.  Chemokines in the immunopathogenesis of hepatitis C infection.

Authors:  Mathis Heydtmann; David H Adams
Journal:  Hepatology       Date:  2009-02       Impact factor: 17.425

8.  Monomeric and dimeric CXCL8 are both essential for in vivo neutrophil recruitment.

Authors:  Sandhya Thulasi Das; Lavanya Rajagopalan; Antonieta Guerrero-Plata; Jiqing Sai; Ann Richmond; Roberto P Garofalo; Krishna Rajarathnam
Journal:  PLoS One       Date:  2010-07-26       Impact factor: 3.240

9.  Site-directed mutagenesis of the CC chemokine binding protein 35K-Fc reveals residues essential for activity and mutations that increase the potency of CC chemokine blockade.

Authors:  Gemma E White; Eileen McNeill; Ivy Christou; Keith M Channon; David R Greaves
Journal:  Mol Pharmacol       Date:  2011-05-17       Impact factor: 4.436

Review 10.  Leukocyte-endothelial interactions in inflammation.

Authors:  Harald F Langer; Triantafyllos Chavakis
Journal:  J Cell Mol Med       Date:  2009-06-16       Impact factor: 5.310

View more

北京卡尤迪生物科技股份有限公司 © 2022-2023.